About HalioDx
HalioDx is a Healthcare company based in Marseille (France) founded in 2015, and was acquired by Veracyte in June 2021. Developer of diagnostic product for colon cancer. HalioDx has raised $31.31 million across 4 funding rounds from investors including Xiaomi, Amundi and Veracyte. The company was acqui-hired. Its focus areas include Life Sciences, Gastroenterology, In Vitro Diagnostic Tests and Gastrointestinal Cancer.
Company details
HalioDx was founded in 2015 in Marseille, France, within the oncology diagnostics sector. Products focused on colon cancer are developed, including assays that assess disease severity, predict treatment responses, and classify tumors molecularly. A range of immunologic scoring tests is offered, such as Immunoscore for colon cancer and non-small cell lung cancer, supporting clinical evaluations in the field.
- Headquarters Marseille, France
- Stage Acquired
- SectorsHealthcare
- Website haliodx.com
- Social LinkedIn X
- Acquired by Veracyte (Jun 2021)
Funding Insights of HalioDx
HalioDx has successfully raised a total of $31.31M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.31M
- Total Rounds 4
- First Round $8.65M
(Mar 2015)
- Investors Count 10
All 4 funding rounds of HalioDx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2019 | Grant | – | – | ||
| Jan 2018 | $22.66M | Series B | – | Quest for Growth | |
| Jan 2018 | $501,659 | Grant | – | – | |
| Mar 2015 | $8.65M | Series A | – | MI care, Sham | – |
11 investors in total: 11 institutional.
Investors in HalioDx
HalioDx has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Xiaomi, Amundi and Veracyte.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital is provided to French companies by the firm. | bnpparibasdeveloppement.com | Paris, France | ||
Equity investments are provided by SOFIPACA for regional business growth. | 1900 | sofipaca.fr | Aix-en-Provence, France | |
Growth-stage life sciences and tech companies in Europe are funded. | 1998 | questforgrowth.com | Leuven, Belgium | |
Private equity investments are made in companies across diverse sectors. | turennecapital.com | Paris, France | ||
Multi-category consumer electronics are offered through an internet-first model. | 2010 | mi.com | Beijing, China | |
Diversified asset management is handled globally from Paris headquarters. | 2010 | amundi.com | Paris, France | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
| MI care | ||||
Offers insurance, risk management, and training for health and territorial entities. | 1927 | sham.fr | Lyon, France |
Investor details for HalioDx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of HalioDx
179 people are tracked at HalioDx (65 in leadership, 8 in board & advisors, 106 in team).
| Name | Role | Group |
|---|---|---|
Ryan Ulaszek | Senior Director, Cloud Architecture | Leadership |
Brad Meyer | Director Of Automation & Process Engineering | Leadership |
John Leite | Chief Commercial Officer | Leadership |
Paul Schock | Director Cloud Devops | Leadership |
Natalia de la Fuente | Associate Director Medical Affairs | Leadership |
Bryan Coon | Vice President, Global Digital Transformation | Leadership |
Jeremy Adams | Director - PMO | Leadership |
Christelle Lautard | Associate Director Continuous Improvement And Compliance | Leadership |
Jerome van Crayelynghe | Director, Supply Chain | Leadership |
Carlo Artieri | Executive Director Of Bioinformatics And Data Science | Leadership |
Brian Niemeyer | Director, Cloud Architecture | Leadership |
Bill Moore | Vice President, Global IT Operations | Leadership |
Roy Coren | Chief Information Security Officer | Leadership |
Irina Rosca | Executive Director Supply Chain And Operations | Leadership |
Oanh Dang | Senior Director, Corporate And Business Development | Leadership |
Timothy Barr | Director Of Market Access | Leadership |
Brad Lotterman Apr | Director Of Communications | Leadership |
Steve Place | Director, Global Marketing Operations | Leadership |
Graham Poage | Director, Market Access | Leadership |
Norah Garrett | Director, Total Rewards | Leadership |
159 more people are available in the full profile.
Complete people profiles for HalioDx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of HalioDx
4 dated milestones of HalioDx across 6 years, from founding to its latest funding, stage changes and deals.
- Founded HalioDx is founded.
- Funding First funding round of $8.7M.
- Funding Latest funding round, Grant,.
- Exit Acquired by Veracyte.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Haliodx
Complete news archive for HalioDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about HalioDx
HalioDx was founded in 2015.
HalioDx is headquartered in Marseille, France. It is registered at Marseille, Provence-alpes-cote D'azur, France.
HalioDx is a funded company, having raised a total of $31.31M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.65M, raised on Mar 2015.
HalioDx was founded in 2015 in Marseille, France, within the oncology diagnostics sector. Products focused on colon cancer are developed, including assays that assess disease severity, predict treatment responses, and classify tumors molecularly. A range of immunologic scoring tests is offered, such as Immunoscore for colon cancer and non-small cell lung cancer, supporting clinical evaluations in the field.
HalioDx has 11 investors. Key investors include Xiaomi, Amundi, Veracyte, European Union, and Quest for Growth.
Yes. HalioDx was acquired by Veracyte in June 2021.